Search clinical trials for: Buprenorphine-naloxone

Total 697 results

Pediatrix

Completed

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome | Neonatal Withdrawal Syndrome

United States
Prisma Health-Upstate
Clemson University

Recruiting

CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine

Opioid-use Disorder

United States
Mundipharma Korea Ltd

Completed

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients (TOP)

Cancer

Korea, Republic of
University Hospital Inselspital, Berne

Completed

Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia

Epidural Analgesia | Radical Cystectomy | Postoperative Pain Management | Oral Oxycodone With/Without Naloxone | Return of the Bowel Function

Switzerland
Medical University of Vienna

Completed

Oral Oxycodone After Major Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery

Austria
Mundipharma Oy

Completed

OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty (OXN4505)

Post Operative Pain

Finland
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Active, not recruiting

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United States
Purdue Pharma LP

Terminated

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

Osteoarthritis

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Opioid Use Disorder
Thomas Jefferson University
National Institute on Drug Abuse (NIDA)

Completed

Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
Purdue Pharma LP
Napp Pharmaceuticals Limited

Completed

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

Chronic Non-malignant Pain

United States, United Kingdom
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Opiate Dependence

United States, Malaysia
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain

Cancer Pain

China
Stanford University
National Institute on Drug Abuse (NIDA)

Completed

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Opioid Withdrawal | Physical Dependence

United States
Arbeitsgemeinschaft medikamentoese Tumortherapie
Roche Pharma AG

Completed

Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL

Lymphoma, Large B-Cell, Diffuse

Austria
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

Healthy

Germany
Artoss Inc.

Completed

Artoss Foot and Ankle Surgery Registry (ARK)

Trauma Injury | Deformity; Bone | Arthritis Foot

United States
Artoss Inc.

Active, not recruiting

Artoss Prospective Spine Registry Outcomes (ASTRO)

Spinal Fusion

United States
Kasr El Aini Hospital
Mansoura University

Completed

Influence Of Low Dose Intrathecal Naloxone On Bupivacaine - Fentanyl Spinal Anaesthesia For Lower Limb Orthopedic Surgery In Elderly Patients

Elderly | Anesthesia, Spinal

Egypt
Senthil Sadhasivam
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute...

Recruiting

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes (Mother/BabyOUD)

Opioid-use Disorder | Opioid Use, Unspecified | Buprenorphine Dependence

United States
BioDelivery Sciences International

Completed

Long-term Open-Label Safety Study to Evaluate EN3409

Osteoarthritis | Low Back Pain | Neuropathic Pain

United States
Purdue Pharma LP

Completed

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Osteoarthritis

United States
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Chronic Low Back Pain

United States
Titan Pharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

Opioid Dependency

United States
Johns Hopkins University
The New York Academy of Medicine

Completed

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants

HIV Infections | HIV Seropositivity | Opiate Dependence

United States
King's College London
South London and Maudsley NHS Foundation Trust

Recruiting

Psilocybin in Depression Resistant to Standard Treatments (PsiDeR)

Treatment Resistant Depression

United Kingdom
Grünenthal GmbH

Completed

Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch

Pain

Switzerland
Stephanie B. Seminara, MD

Enrolling by invitation

Opioid Antagonism in Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United States
Loyola University

Recruiting

Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery

Pain, Postoperative

United States
Fox Chase Cancer Center

Recruiting

Buprenorphine for Cancer Pain

Cancer-Related Pain

United States
Prisma Health-Upstate
National Institute on Drug Abuse (NIDA); Clemson University

Recruiting

An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder (OVERCOME 2)

Standard of Care | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RC

United States
Orexo AB
Worldwide Clinical Trials

Completed

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults (ISTART)

Opioid Dependence, on Agonist Therapy

United States
Dartmouth-Hitchcock Medical Center

Completed

Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
Heidelberg University

Recruiting

Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody (FORTplus)

Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a

Germany
Cairo University

Unknown

Evaluation of Marginal Bone Loss After Immediate Implant Placement in Maxillary Esthetic Zone With Nanobone Versus Xenograft

Implant Placement in Maxillary Esthetic Zone

Egypt
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Opiate Dependence

United States, Malaysia
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

HIV Risk Reduction and Drug Abuse Treatment in Iran

HIV Infections | Opiate Dependence

United States, Iran, Islamic Republic of
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effective Treatment for Prescription Opioid Abuse

Prescription Opioid Dependence

United States
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Jessica Merlin
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment (TREETOP)

Chronic Pain | Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

Dependence, Opioid

United States
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

Buprenorphine Transdermal Patches Pharmacokinetic Study

Chronic Pain

China
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1

Pregnancy | Opiate Dependence

United States
Kuopio University Hospital

Withdrawn

Naloxone Methadone Combination (NAMEKO) (NAMEKO)

Opiate Dependence

Finland
National Institute on Alcohol Abuse and Alcoholism...

Completed

Medication and Counseling for Controlled Drinking (Project SMART)

Alcohol Drinking | Alcoholism | Alcohol Abuse | Alcohol-related Disorders

United States
Elizabeth Krans, MD
National Institute on Drug Abuse (NIDA); OpalGenix, Inc

Recruiting

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Pregnancy Related | Opioid Use Disorder

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Montefiore Medical Center; Fordham University

Completed

Neurocognitive Effects of Opiate Agonist Treatment (NEO)

HIV Infections | HIV | Opioid-Related Disorders

United States

Search clinical trials for: Buprenorphine-naloxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations